Stemson Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Stemson Therapeutics's estimated annual revenue is currently $6.4M per year.(i)
  • Stemson Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Stemson Therapeutics has 41 Employees.(i)
  • Stemson Therapeutics grew their employee count by 32% last year.

Stemson Therapeutics's People

NameTitleEmail/Phone
1
Co-Founder, CEOReveal Email/Phone
2
Co-Founder, Key Scientific AdvisorReveal Email/Phone
3
VP, Product Development & Tissue EngineeringReveal Email/Phone
4
VP, R&D and Preclinical DevelopmentReveal Email/Phone
5
Chief Scientific OfficerReveal Email/Phone
6
Associate Scientific DirectorReveal Email/Phone
7
Director Histology and Pathology DepartmentReveal Email/Phone
8
Senior Director BioInformatics and Data SciencesReveal Email/Phone
9
Director Histology & PathologyReveal Email/Phone
10
Director Histology and Pathology DepartmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Stemson Therapeutics?

At Stemson Therapeutics, we envision a world where anyone battling the emotional trauma or social stigma of hair loss has an opportunity to truly cure their condition and safely restore their natural hair.

keywords:N/A

N/A

Total Funding

41

Number of Employees

$6.4M

Revenue (est)

32%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Stemson Therapeutics News

2022-04-13 - Paul Laikind, PhD, Joins Stemson Therapeutics Board of ...

Stemson Therapeutics is a pre-clinical stage cell therapy company founded in 2018 with a mission to cure hair loss by leveraging the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.1M41-18%N/A
#2
$4.8M418%N/A
#3
$7.5M41-13%$269.2M
#4
$3.2M41-35%$39.4M
#5
$8.9M413%N/A